Clinical Trial Update: Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses [Phase 4]

View source ↗

Summary

This clinical trial update reports on the use of PEG-asparaginase during two treatment courses in pediatric acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• PEG-asparaginase (polyethylene glycol-asparaginase)

Snippet

Sponsor: Nordic Society for Pediatric Hematology and Oncology | Conditions: Acute Lymphoblastic Leukemia | Phase 4 | Status: UNKNOWN